Oscar Health, Inc. $OSCR Shares Bought by Park West Asset Management LLC

Key Points

Error: Response status code does not indicate success: 502 (Bad Gateway).

Park West Asset Management LLC lifted its position in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 36.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,263,973 shares of the company's stock after acquiring an additional 338,973 shares during the period. Park West Asset Management LLC owned 0.50% of Oscar Health worth $16,571,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in Oscar Health by 3.7% during the 1st quarter. Vanguard Group Inc. now owns 19,698,442 shares of the company's stock valued at $258,247,000 after purchasing an additional 700,469 shares during the last quarter. T. Rowe Price Investment Management Inc. lifted its holdings in shares of Oscar Health by 4.1% during the first quarter. T. Rowe Price Investment Management Inc. now owns 11,826,245 shares of the company's stock worth $155,043,000 after purchasing an additional 467,301 shares during the period. Thrive Capital Management LLC boosted its position in Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock valued at $85,258,000 after buying an additional 1,588,395 shares during the last quarter. BIT Capital GmbH boosted its position in Oscar Health by 1.1% in the first quarter. BIT Capital GmbH now owns 4,521,445 shares of the company's stock valued at $59,276,000 after buying an additional 47,592 shares during the last quarter. Finally, Southeastern Asset Management Inc. TN increased its holdings in Oscar Health by 52.2% in the 4th quarter. Southeastern Asset Management Inc. TN now owns 3,131,084 shares of the company's stock worth $42,082,000 after buying an additional 1,073,359 shares during the period. Institutional investors and hedge funds own 75.70% of the company's stock.

Wall Street Analysts Forecast Growth

OSCR has been the subject of several research reports. Wall Street Zen cut shares of Oscar Health from a "hold" rating to a "sell" rating in a research note on Saturday, August 9th. Barclays reduced their target price on shares of Oscar Health from $17.00 to $11.00 and set an "underweight" rating for the company in a report on Wednesday, July 23rd. Robert W. Baird reaffirmed a "neutral" rating and issued a $14.00 price target (down from $28.00) on shares of Oscar Health in a report on Friday, July 25th. Raymond James Financial downgraded Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. Finally, Wells Fargo & Company cut Oscar Health from an "equal weight" rating to an "underweight" rating and decreased their price objective for the company from $16.00 to $10.00 in a report on Friday, July 11th. Four equities research analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Strong Sell" and an average target price of $12.07.

Oscar Health Stock Performance

OSCR stock traded down $0.04 during midday trading on Thursday, hitting $19.44. 12,260,842 shares of the stock traded hands, compared to its average volume of 13,799,354. Oscar Health, Inc. has a 1-year low of $11.20 and a 1-year high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.86 and a quick ratio of 0.86. The stock's fifty day simple moving average is $15.81 and its 200-day simple moving average is $15.10. The firm has a market cap of $5.03 billion, a P/E ratio of -24.00 and a beta of 1.87.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.90) by $0.01. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The business had revenue of $2.86 billion for the quarter, compared to analyst estimates of $2.88 billion. During the same period in the prior year, the company posted $0.20 EPS. The company's revenue for the quarter was up 29.0% on a year-over-year basis. On average, analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.